Creating a Platform to Cure the Most Difficult Diseases

2

Leave a Reply

Your email address will not be published. Required fields are marked *

MiCAN will accelerate infectious disease research through special cells created with regenerative medicine technology. Many bio ventures are focusing on transplantation material or tissue using regenerative medicine technologies. But we focus on immature or intermediate blood cells that are difficult to collect from donor blood. Initially we are developing our products for infectious disease. One of our core technologies is the differentiation methods how to provide these young cells. Most of our customers are in abroad because of the target disease. So, we will provide our product from Japan to all over the world.

TEAM

KAZUO MIYAZAKI

CEO

Background: Drug researcher at Pharma Co.
Expertise: Small molecule drugs / Regenerative Medicine

MBA

MINORU OKADA

CTO

Background: Product development at Pharma Co.
Expertise: Cell engineering / Regenerative Medicine

PhD

FINANCE ROUND

Angel

MiCAN Technologies Inc.

Company Profile

URL:
http://www.micantechnologies.com/
Address:
KKVP206, Goryo-ohara 1-36, Nshigyo-Ku, Kyoto, 615-8245, Japan
Founded:
July, 2016
Capital:
JPY 15,580,000
Employee:
4
Branch Office:

Visitor

OPERATED BY